Inhibition of interleukin-2 gene expression by human herpesvirus 6B U54 tegument protein

Journal of Virology

Volumn 88, Issue 21, 2014, Pages 12452-12463

  Iampietro, Mathieu ^a   Morissette, Guillaume ^a   Gravel, Annie ^a   Flamand, Louis ^a,b  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; HERPESVIRUS 6B U54 TEGUMENT PROTEIN; INTERLEUKIN 2; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT 1; TRANSCRIPTION FACTOR NFAT 2; TRANSCRIPTION FACTOR NFAT3; UNCLASSIFIED DRUG; VIRUS PROTEIN; CALCINEURIN PHOSPHATASE; IL2 PROTEIN, HUMAN; PHOSPHATASE; PROTEIN BINDING;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; IL2 GENE; IMMUNE EVASION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PROTEIN DEPHOSPHORYLATION; ULTRAVIOLET IRRADIATION; VIRUS IDENTIFICATION; VIRUS MORPHOLOGY; ANTAGONISTS AND INHIBITORS; CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

CELL LINE; HERPESVIRUS 6, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERLEUKIN-2; NFATC TRANSCRIPTION FACTORS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN BINDING; VIRAL PROTEINS;

EID: 84907977336     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02030-14     Document Type: Article

References (62)

1. Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GR, Kramarsky B, Salahuddin SZ, Gallo RC. 1991. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 184:545-552. http://dx.doi.org/10.1016/0042-6822(91)90424-A.
2. Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, Diluca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Hollsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T. 2014. Classification of HHV-6A and HHV-6B as distinct viruses. Arch. Virol. 159:863-870. http: //dx.doi.org/10.1007/s00705-013-1902-5.
3. Adams MJ, Carstens EB. 2010. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012). Arch. Virol. 157:1411-1422. http://dx.doi.org/10.1007/s00705-012-1299-6.
4. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, et al. 1986 Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601. http://dx.doi.org/10.1126/science.2876520.
5. Lopez C, Pellett P, Stewart J, Goldsmith C, Sanderlin K, Black J, Warfield D, Feorino P. 1988. Characteristics of human herpesvirus-6. J. Infect. Dis. 157:1271-1273. http://dx.doi.org/10.1093/infdis/157.6.1271.
6. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i:1065-1067.
7. Scheurer ME, Pritchett JC, Amirian ES, Zemke NR, Lusso P, Ljungman P. 2013. HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transplant. 48:574-580 http://dx.doi.org/10.1038/bmt.2012.180.
8. Lusso P, Markham PD, Tschachler E, di Marzo Veronese F, Salahuddin SZ, Ablashi DV, Pahwa S, Krohn K, Gallo RC. 1988. In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J. Exp. Med. 167:1659-1670. http://dx.doi.org/10.1084/jem.167.5.1659.
9. Takahashi K, Sonoda S, Higashi K, Kondo T, Takahashi H, Takahashi M, Yamanishi K. 1989. Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J. Virol. 63:3161-3163.
10. Lusso P, Malnati M, De Maria A, Balotta C, DeRocco SE, Markham PD, Gallo RC. 1991. Productive infection of CD4+and CD8+mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J. Immunol. 147:685-691.
11. Lusso P, De Maria A, Malnati M, Lori F, DeRocco SE, Baseler M, Gallo RC. 1991. Induction of CD4 and susceptibility to HIV-1 infection in human CD8+T lymphocytes by human herpesvirus 6. Nature 349:533-535. http://dx.doi.org/10.1038/349533a0.
12. Flamand L, Romerio F, Reitz MS, Gallo RC. 1998. CD4 promoter transactivation by human herpesvirus 6. J. Virol. 72:8797-8805.
13. Wang F, Yao K, Yin QZ, Zhou F, Ding CL, Peng GY, Xu J, Chen Y, Feng DJ, Ma CL, Xu WR. 2006. Human herpesvirus-6-specific interleukin 10-producing CD4+ T cells suppress the CD4+ T-cell response in infected individuals. Microbiol. Immunol. 50:787-803. http://dx.doi.org /10.1111/j.1348-0421.2006.tb03855.x.
14. Grivel JC, Ito Y, Faga G, Santoro F, Shaheen F, Malnati MS, Fitzgerald W, Lusso P, Margolis L. 2001. Suppression of CCR5-but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat. Med. 7:1232-1235. http://dx.doi.org/10.1038/nm1101-1232.
15. Jaworska J, Gravel A, Fink K, Grandvaux N, Flamand L. 2007. Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein. J. Virol. 81:5737-5748. http://dx.doi.org/10.1128/JVI.02443-06.
16. Jaworska J, Gravel A, Flamand L. 2010. Divergent susceptibilities of human herpesvirus 6 variants to type I interferons. Proc. Natl. Acad. Sci. U. S. A. 107:8369-8374. http://dx.doi.org/10.1073/pnas.0909951107.
17. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. 1995. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 85: 1263-1271.
18. Horvat RT, Parmely MJ, Chandran B. 1993. Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells. J. Infect. Dis. 167:1274-1280. http://dx.doi.org/10.1093/infdis /167.6.1274.
19. Wang FZ, Larsson K, Linde A, Ljungman P. 2002. Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients. Bone Marrow Transplant. 30: 521-526. http://dx.doi.org/10.1038/sj.bmt.1703657.
20. Gillis S, Smith KA. 1977. Long term culture of tumour-specific cytotoxic T cells. Nature 268:154-156. http://dx.doi.org/10.1038/268154a0.
21. Malek TR. 2008. The biology of interleukin-2. Annu. Rev. Immunol. 26:453-479 http://dx.doi.org/10.1146/annurev.immunol.26.021607.090357.
22. Morgan DA, Ruscetti FW, Gallo R. 1976. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007-1008. http://dx.doi.org/10.1126/science.181845.
23. Jain J, Loh C, Rao A. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7:333-342. http://dx.doi.org/10.1016/0952-7915 (95)80107-3.
24. Serfling E, Avots A, Neumann M. 1995. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim. Biophys. Acta 1263:181-200. http://dx.doi.org/10.1016/0167-4781(95)00112-T.
25. Shaw J, Meerovitch K, Bleackley RC, Paetkau V. 1988. Mechanisms regulating the level of IL-2 mRNA in T lymphocytes. J. Immunol. 140: 2243-2248.
26. Boise LH, Petryniak B, Mao X, June CH, Wang CY, Lindsten T, Bravo R, Kovary K, Leiden JM, Thompson CB. 1993. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol. Cell. Biol. 13:1911-1919.
27. Hogan PG, Chen L, Nardone J, Rao A. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17:2205-2232. http://dx.doi.org/10.1101/gad.1102703.
28. Macian F. 2005. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5:472-484. http://dx.doi.org/10.1038 /nri1632.
29. Serfling E, Berberich-Siebelt F, Chuvpilo S, Jankevics E, Klein-Hessling S, Twardzik T, Avots A. 2000. The role of NF-AT transcription factors in T cell activation and differentiation. Biochim. Biophys. Acta 1498:1-18. http://dx.doi.org/10.1016/S0167-4889(00)00082-3.
30. Aramburu J, Garcia-Cozar F, Raghavan A, Okamura H, Rao A, Hogan PG. 1998. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol. Cell 1:627-637. http://dx.doi.org/10.1016/S1097-2765(00)80063-5.
31. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A. 1999. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285:2129-2133. http://dx.doi.org/10.1126/science.285.5436.2129.
32. Garcia-Cozar FJ, Okamura H, Aramburu JF, Shaw KT, Pelletier L, Showalter R, Villafranca E, Rao A. 1998. Two-site interaction of nuclear factor of activated T cells with activated calcineurin. J. Biol. Chem. 273: 23877-23883. http://dx.doi.org/10.1074/jbc.273.37.23877.
33. Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. 2009. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 4:e6529. http://dx.doi.org/10.1371/journal.pone.0006529.
34. Tomoiu A, Gravel A, Tanguay RM, Flamand L. 2006. Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation. J. Virol. 80: 10218-10228. http://dx.doi.org/10.1128/JVI.00375-06.
35. Josephs SF, Salahuddin SZ, Ablashi DV, Schachter F, Wong-Staal F, Gallo RC. 1986. Genomic analysis of the human B-lymphotropic virus (HBLV). Science 234:601-603. http://dx.doi.org/10.1126/science.3020691.
36. Northrop JP, Ullman KS, Crabtree GR. 1993. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J. Biol. Chem. 268:2917-2923.
37. Hoey T, Sun YL, Williamson K, Xu X. 1995. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2:461-472. http://dx.doi.org/10.1016/1074-7613(95)90027-6.
38. Gravel A, Gosselin J, Flamand L. 2002. Human herpesvirus 6 immediateearly 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukemia protein-associated nuclear bodies. J. Biol. Chem. 277:19679-19687. http://dx.doi.org/10.1074/jbc.M200836200.
39. Chow CW, Rincon M, Davis RJ. 1999. Requirement for transcription factor NFAT in interleukin-2 expression. Mol. Cell. Biol. 19:2300-2307.
40. Macian F, Garcia-Rodriguez C, Rao A. 2000. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 19:4783-4795. http://dx.doi.org/10.1093/emboj/19.17.4783.
41. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. 2005. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin. Infect. Dis. 40:932-940. http://dx.doi.org/10.1086/428060.
42. Roffman E, Frenkel N. 1990. Interleukin-2 inhibits the replication of human herpesvirus-6 in mature thymocytes. Virology 175:591-594. http: //dx.doi.org/10.1016/0042-6822(90)90447-Y.
43. Kalejta RF. 2008. Tegument proteins of human cytomegalovirus. Microbiol. Mol. Biol. Rev. 72:249-265. http://dx.doi.org/10.1128/MMBR.00040-07.
44. Tomtishen JP, III. 2012. Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28). Virol. J. 9:22. http://dx.doi.org/10.1186/1743-422X-9-22.
45. Sieber M, Baumgrass R. 2009. Novel inhibitors of the calcineurin/NFATc hub-alternatives to CsA and FK506? Cell Commun. Signal. 7:25. http: //dx.doi.org/10.1186/1478-811X-7-25.
46. Fruman DA, Klee CB, Bierer BE, Burakoff SJ. 1992. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl. Acad. Sci. U. S. A. 89:3686-3690. http://dx.doi.org/10.1073 /pnas.89.9.3686.
47. Perrino BA. 1999. Regulation of calcineurin phosphatase activity by its autoinhibitory domain. Arch. Biochem. Biophys. 372:159-165. http://dx.doi.org/10.1006/abbi.1999.1485.
48. Sagoo JK, Fruman DA, Wesselborg S, Walsh CT, Bierer BE. 1996. Competitive inhibition of calcineurin phosphatase activity by its autoinhibitory domain. Biochem. J. 320:879-884.
49. Roehrl MH, Kang S, Aramburu J, Wagner G, Rao A, Hogan PG. 2004. Selective inhibition of calcineurin-NFAT signaling by blocking proteinprotein interaction with small organic molecules. Proc. Natl. Acad. Sci. U. S. A. 101:7554-7559. http://dx.doi.org/10.1073/pnas.0401835101.
50. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099-1102. http://dx.doi.org/10.1126/science.1086871.
51. Miskin JE, Abrams CC, Goatley LC, Dixon LK. 1998. A viral mechanism for inhibition of the cellular phosphatase calcineurin. Science 281:562-565 http://dx.doi.org/10.1126/science.281.5376.562.
52. Granja AG, Perkins ND, Revilla Y. 2008. A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300. J. Immunol. 180:2429-2442. http://dx.doi.org/10.4049/jimmunol.180.4.2429.
53. Granja AG, Nogal ML, Hurtado C, Vila V, Carrascosa AL, Salas ML, Fresno M, Revilla Y. 2004. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway. J. Biol. Chem. 279:53736-53746. http://dx.doi.org/10.1074/jbc.M406620200.
54. Matsuda S, Shibasaki F, Takehana K, Mori H, Nishida E, Koyasu S. 2000 Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO Rep. 1:428-434. http: //dx.doi.org/10.1093/embo-reports/kvd090.
55. Miskin JE, Abrams CC, Dixon LK. 2000. African swine fever virus protein A238L interacts with the cellular phosphatase calcineurin via a binding domain similar to that of NFAT. J. Virol. 74:9412-9420. http://dx.doi.org/10.1128/JVI.74.20.9412-9420.2000.
56. Loret S, Guay G, Lippe R. 2008. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J. Virol. 82:8605-8618. http://dx.doi.org/10.1128/JVI.00904-08.
57. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DG, II, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA. 2004. Identification of proteins in human cytomegalovirus (HCMV) particles: theHCMVproteome. J. Virol. 78:10960-10966 http://dx.doi.org/10.1128/JVI.78.20.10960-10966.2004.
58. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. 2008 Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9:194-202. http://dx.doi.org/10.1038/ni1549.
59. Kim HP, Korn LL, Gamero AM, Leonard WJ. 2005. Calcium-dependent activation of interleukin-21 gene expression in T cells. J. Biol. Chem. 280: 25291-25297. http://dx.doi.org/10.1074/jbc.M501459200.
60. Shen F, Hu Z, Goswami J, Gaffen SL. 2006. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem. 281:24138-24148. http://dx.doi.org/10.1074/jbc.M604597200.
61. Muller MR, Rao A. 2010. NFAT, immunity and cancer: a transcription factor comes of age. Nat. Rev. Immunol. 10:645-656. http://dx.doi.org/10.1038/nri2818.
62. Iampietro M, Gravel A, Flamand L. 2014. Inhibition of breast cancer cell proliferation throguh disturbance of the calcineurin/NFAT pathway by human herpesvirus 6B U54 tegument protein. J. Virol. 88:12910-12914. http://dx.doi.org/10.1128/JVI.02107-14.